JanOne Inc. 是一家臨床階段生物製藥公司,專注於識別、收購、授權、開發、合作及商業化新型非鴉片類及非成癮性療法,以應對疼痛管理方面尚未滿足的醫療需求。該公司總部位於內華達州拉斯維加斯。
財務指標
營業收入
2026-06-30
$216.45M
2026-03-31
$200.34M
2025-06-30
$148.85M
2025-03-31
$148.92M
營業支出
2026-06-30
$60.62M
2026-03-31
-$48.11M
2025-06-30
$145.36M
2025-03-31
$146.56M
淨利潤
2026-06-30
$10.72M
2026-03-31
$31.33M
2025-06-30
-$2.57M
2025-03-31
-$2.11M
淨利潤率
2026-06-30
4.95%
2026-03-31
15.63%
2025-06-30
-1.72%
2025-03-31
-1.41%
每股收益
2026-06-30
$0.24
2026-03-31
$0.01
2025-06-30
--
2025-03-31
--
息稅折舊攤銷前利潤
2026-06-30
$56.47M
2026-03-31
$80.74M
2025-06-30
$30.65M
2025-03-31
$32.77M
有效稅率
2026-06-30
13.31%
2026-03-31
3.86%
2025-06-30
--
2025-03-31
--
項目
2026-06-30
2026-03-31
2025-06-30
2025-03-31
營業收入
$216.45M
$200.34M
$148.85M
$148.92M
營業支出
$60.62M
-$48.11M
$145.36M
$146.56M
淨利潤
$10.72M
$31.33M
-$2.57M
-$2.11M
淨利潤率
4.95%
15.63%
-1.72%
-1.41%
每股收益
$0.24
$0.01
--
--
息稅折舊攤銷前利潤
$56.47M
$80.74M
$30.65M
$32.77M
有效稅率
13.31%
3.86%
--
--
常見問題
JAN is the Nasdaq ticker symbol for Janover Inc., a U.S.-based financial technology company. Janover operates a platform focused on commercial real estate financing and small business lending, connecting borrowers with lenders. The company is headquartered in Boca Raton, Florida, and went public in 2023. Because JAN represents this specific company, its stock performance reflects developments in Janover's business, including its lending marketplace and any newer strategic initiatives.
JAN's recent performance is shown on the stock detail page, including the latest price, daily change, and percentage move. That page also provides historical price charts and a 52-week range for context. Since JAN is a small-cap stock, its price can react sharply to company announcements, financing updates, and shifts in market sentiment toward small-cap and fintech names. For the most current performance figures, refer to the live data displayed on this page rather than relying on outdated figures.
Trading activity in JAN is best measured through average daily volume, bid-ask spreads, and recent turnover, all of which appear in the market data section of this page. Small-cap stocks like JAN often have lower liquidity than large-cap peers, which can mean wider spreads and more price movement per trade. Investors should check the displayed volume and spread data before placing orders to understand execution conditions.
Valuation analysis for JAN typically involves price-to-sales, price-to-book, and enterprise-value ratios, since small-cap fintech companies often have limited or negative earnings. Comparing these multiples with peers in the financial technology and lending platform space can provide context. Because valuations can change with the share price and reported financials, the most current metrics are the ones shown on this JAN stock page.
Whether JAN pays a dividend depends on the company's capital return policy at any given time. Janover has historically not emphasized dividend payments, as growth-oriented small-cap companies often retain earnings for operations and expansion. The dividend section on this page shows any declared dividends, payment history, and yield information if applicable. Investors should verify the latest status there, as corporate policies can change.
JAN carries risks common to small-cap, early-stage fintech companies. These include limited operating history, the need for additional capital, exposure to commercial real estate and credit conditions, and potential volatility from low liquidity. Regulatory changes affecting lending platforms and competition from larger financial institutions also matter. Because these factors are company- and market-specific, investors should review Janover's SEC filings and the risk disclosures linked from this page.